1Department of Pharmacy Practice, Srinivas College of Pharmacy, Manglore-574143
2Department of Pharmacy Practice, Srinivas College of Pharmacy Manglore-574143
3Department of Pharmaceutics, Srinivas College of Pharmacy,Manglore-574143
India launched the COVID-19 booster dose vaccinations on July 15 2022; however there wasn't much acceptance of it. Implementing a self-administered questionnaire, a prospective observational study was undertaken among the general public in Mangalore from 30th Jan 2022-11th Sep 2022, with the purpose of determining the acceptance and challenges of the COVID-19 vaccination. Social Science Software was used to examine the data. Chi-square test was used to assess the association between vaccine acceptance, demographic & non-demographic factors. Socio demographic characteristic influenced non vaccination. Majority of males (78%), urban residence (49%) university level education (40%), age >60 years with co-morbidity (62%) had high acceptance, but it was less in 3rd (15%) comparing with 1st (13%) and 2nd (72%) dose, often cited reasons for accepting vaccine were family/friends advice, fear of contracting disease and govt awareness camp. Social habits (37.5%), myths viz religiosity (33%), menstruation and infertility (41%), weakening of immunity (41%), contributed for non acceptance, but in 3rd dose concerns about fear of long term effects (76%), economy (32%), social media (7%) and having no reasons (5.6%).This study concludes a high level of COVID-19 booster dose vaccine hesitancy among Public. Efforts to provide accurate information on vaccine safety and effectiveness are highly recommended..
Satish S, Divina Radhakrishna Gowda*, Ar Shabaraya A Study On Acceptance Of Covid-19 Vaccination (Booster Dose) Among General Public In Dakshina Kannada, Int. J. in Pharm. Sci., 2023, Vol 1, Issue 11, 430-442. https://doi.org/10.5281/zenodo.10201283
10.5281/zenodo.10201283
